Zhao Yawen, Liu Xiujuan, Zhang Wei, Yuan Yun
Department of Neurology, Peking University First Hospital, Beijing, 100034, China.
Muscle Nerve. 2017 Dec;56(6):1181-1187. doi: 10.1002/mus.25575. Epub 2017 Apr 8.
The aim of this study was to describe the therapeutic effects of immunomodulatory therapy in 3 patients with childhood autoimmune necrotizing myopathy with anti-signal recognition particle antibodies (SRP-ANM).
Before treatment, data on clinical features, muscle pathology, and thigh MRIs were obtained. After definitive diagnoses, all 3 patients were treated with intravenous immunoglobulin and corticosteroids, and thigh MRIs were performed.
Clinical improvements were associated with declines in serum creatine kinase levels. Pretreatment thigh MRIs revealed diffuse, but uneven or focal edema, mostly in the posterior thigh muscles, which was alleviated after immunomodulatory therapy.
Childhood SRP-ANM responded well to immunomodulatory therapy. The extent of edema, as monitored by thigh MRI, appears to be a useful marker of disease severity and therapeutic benefit. Muscle Nerve 56: 1181-1187, 2017.
本研究旨在描述免疫调节疗法对3例患有抗信号识别颗粒抗体(SRP-ANM)的儿童自身免疫性坏死性肌病患者的治疗效果。
在治疗前,获取临床特征、肌肉病理学和大腿MRI数据。确诊后,所有3例患者均接受静脉注射免疫球蛋白和皮质类固醇治疗,并进行大腿MRI检查。
临床改善与血清肌酸激酶水平下降相关。治疗前大腿MRI显示弥漫性但不均匀或局灶性水肿,主要位于大腿后部肌肉,免疫调节治疗后水肿减轻。
儿童SRP-ANM对免疫调节疗法反应良好。通过大腿MRI监测的水肿程度似乎是疾病严重程度和治疗效果的有用指标。《肌肉与神经》56: 1181 - 1187, 2017年。